From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Psychiatry>
  4. Summary and Comment

Converging on Genes for Schizophrenia

Data from animals, humans, autopsies, and electrophysiology identify a variant potassium-channel gene and suggest its role in a core feature of schizophrenia.

Researchers have not identified a causative gene for schizophrenia, a group of disorders with complex interactions between genetically and epigenetically influenced traits. Unlike most studies using single lines of investigation, this landmark series of experiments used data on animals, humans, autopsies, and electrophysiology that converged on a core feature of schizophrenia.

First, the researchers studied single nucleotide polymorphisms (SNPs) in 10 candidate genes in 170 European families with offspring who had schizophrenia. The most robust association with schizophrenia risk was in a region in chromosome 7 that codes for the voltage-activated delayed-rectifier potassium channel KCNH2. In healthy unrelated subjects, three KCNH2 SNPs were significantly associated with:

  • Lower IQ and slower information-processing speed (cognitive findings previously associated with genetic risk for schizophrenia in discordant twins)
  • Smaller hippocampal volume on MRI
  • On functional MRI, greater hippocampal activation (indicating inefficient memory processing) during a memory test and inefficient processing in the dorsolateral prefrontal cortex (DLPFC) during an executive-function test

In a postmortem study, KCNH2 mRNA expression was lower in the DLPFC and hippocampus of schizophrenia patients than of controls. This finding might be independent of medication effects: In rats, chronic exposure to antipsychotic drugs did not alter KCNH2 expression.

A KCNH2 variant (KCNH2-3.1), a brain-specific primate gene, had hippocampal mRNA expression that was greater in schizophrenia patients than in controls and was associated with the risk SNPs. In brain samples, KCNH2-3.1 expression increased prenatally and then decreased after birth. In transfected neurons, KCNH2-3.1 overexpression was associated with decreased activation and faster deactivation of the rectifier potassium current, resulting in a high-frequency and nonadaptive pattern of neuronal firing.

Comment: An editorialist notes the unique specificity and breadth of these studies. The researchers used multiple experimental paradigms to identify and characterize a variant potassium-channel gene associated with schizophrenia and with information-processing disturbances in normal people. The variant is specific to primates and appears to interfere with cognition by altering neuronal repolarization, resulting in excessive neuronal firing that decreases the signal-to-noise ratio. This might contribute to defective gating of information, a core cognitive deficit of schizophrenia, which clinically manifests as an inability to discriminate between relevant and irrelevant social and psychological data. Normal people with this deficit might be socially and cognitively odd (e.g., schizotypal or schizoid); those who are also vulnerable to psychosis might develop schizophrenia. Eventually, specific brain KCNH2-3.1 blockers might normalize information processing without producing QT prolongation from the blockade of potassium efflux channels in the heart.

Steven Dubovsky, MD

Published in Journal Watch Psychiatry July 13, 2009

Citation(s):

Huffaker SJ et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 2009 May; 15:509.

Horváth S and Mirnics K. Breaking the gene barrier in schizophrenia. Nat Med 2009 May; 15:488.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.